UPDATE: Citi Raises PT on AmSurg Corp to $32.50 (AMSG)

Citi released its report yesterday on AmSurg Corp AMSG, raising its PT from $24 to $32.50. In a note to clients, Citi writes, "This afternoon AMSG announced the acquisition of Dallas based National Surgical Care, a private multi-specialty provider with 18 ASCs. The deal should add $125m annual revs and at least 16c EPS (+8-9%) annualized. We are raising our price target to $32.50 and remain the only Buy-rating on the Street. Even after Thursday's 6% move, we still est a 10% proforma trailing FCF yield." Shares of AMSG closed Thursday at $27.35.